I am BIO Podcast

Powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.

Join Our Email List

Listen on
Apple Podcast

Listen on
Google Podcast

Listen on
Spotify

Featured Episodes & More

Is CRISPR the New Sickle Cell Savior?

A 2023 biotech breakthrough: CRISPR gene-editing therapy offers new hope for 100,000 Americans with sickle cell. Hear from CASGEVY's creators and patient advocates in this episode.

Listen Now

Biotech is Climate Tech

Biotech tackles climate change with innovations, from carbon-neutral facilities to reducing emissions. At COP28, BIO highlighted that biotech is key to climate tech.

Learn More

Editing Cells Within the Body—a New CRISPR Frontier

CRISPR, biotech's rising star, reached a 2023 milestone with FDA approval for a sickle cell treatment. This episode explores the future of in-body gene editing with two pioneering companies.

Learn More

Listener takeover: Your Biotech Questions Answered

In this episode, experts answer your questions on GMO safety, personalized medicine, feeding the world by 2050, and what attracts investors to start-ups.

Learn More

Lessons from Monkeypox: Are We Prepared for the Next Pandemic?

Episode 62 • Oct 4, 2022 • 18 min

Monkeypox hit our shores in May of this year. How did our public health agencies and infrastructure perform? What went right, what went wrong, and what needs to improve? We talked with three experts in public health and biodefense about the threats on their radar screens and how the U.S. can better prepare for the next inevitable outbreak or pandemic.

Listen Now

Science Helped Save the World from COVID. What will Vaccine Technology do Next?

Episode 56 • Apr 5, 2022 • 24 min

2021 was the unofficial year of mRNA—and deservedly so. But the science behind the technology is not always easy to understand. In this episode, we will dive into the miracle technology that saved countless lives and talk about what it holds for the future. We also speak to a biotech company about its non-mRNA vaccine technology for COVID and why the healthcare ecosystem will always need multiple options.